| Financial Year |
March 31 2023 |
| Monetary Funds |
625,681,712.53 |
| Held-for-trading Financial Assets |
20,046,246.57 |
| Notes Receivable |
-- |
| Accounts Receivable |
15,236,611.95 |
| Advances to Suppliers |
4,573,481.35 |
| Other Receivables |
2,783,729.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
676,172.64 |
| Dividend Receivable |
-- |
| Inventories |
163,400,904.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,070,998.01 |
| Total Current Assets |
832,793,684.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
983,285,979.56 |
| Under-construction Projects |
228,270,207.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
51,658,207.16 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
457,250.58 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
36,054,256.87 |
| Sub-Total of Non-Current Assets |
1,306,596,006.29 |
| Total Assets |
2,139,389,690.40 |
| Short-Term Loans |
24,022,000.01 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
56,205,135.49 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,369,134.70 |
| Taxes Payable |
898,873.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
29,556,185.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
48,561,789.22 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
181,312,213.91 |
| Long-term Loans |
244,356,650.57 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
292,077,125.54 |
| Total Liabilities |
473,389,339.45 |
| Paid-In Capital(Or Share Stock) |
116,700,000.00 |
| Capital Surplus |
843,928,623.03 |
| Surplus Reserve |
21,976,268.59 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
657,844,659.25 |
| Minority Stockholder's Interest |
25,550,800.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,640,449,550.87 |
| Owner's Equity（Stockholder's Equity） |
1,666,000,350.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,139,389,690.40 |
